iBio, Inc. (IBIO)
1.97
+0.02
(+1.03%)
USD |
NASDAQ |
Apr 02, 11:16
iBio EPS Diluted (Quarterly) : -0.0907 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Bristol Myers Squibb Co. | 0.5326 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.993M |
| Total Expenses (Quarterly) | 8.993M |
| Enterprise Value | 17.11M |
| Earnings Yield | -49.76% |
| Normalized Earnings Yield | -48.88 |